“…The use of nanotechnology in nerve regeneration therapy has gained increasing interest. The main uses include the production of biomaterials (natural or synthetic) for the development of scaffolds and nerve guidance conduits ( Gerth et al, 2015 ; Sarker et al, 2018 ), or for implementing smart drug delivery ( Tajdaran et al, 2019 ; Bianchini et al, 2023 ). Of these, MNPs have been effectively used for the delivery of growth factors, such as nerve growth factor (NGF) ( Ziv-Polat et al, 2014 ; Zuidema et al, 2015 ; Giannaccini et al, 2017 ; Marcus et al, 2018 ), brain-derived neurotrophic factor (BDNF) ( Pilakka-Kanthikeel et al, 2013 ; Wise et al, 2016 ), glial cell line-derived neurotrophic factor (GDNF) ( Ziv-Polat et al, 2014 ), vascular endothelial growth factor (VEGF) ( Giannaccini et al, 2017 ) to promote nerve survival and neurite regeneration ( Zuidema et al, 2015 ; Wise et al, 2016 ; Giannaccini et al, 2017 ).…”